Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

BUY
$16.59 - $23.77 $1,128 - $1,616
68 Added 0.23%
29,321 $509,000
Q2 2023

Aug 03, 2023

SELL
$19.27 - $24.63 $90,202 - $115,293
-4,681 Reduced 13.79%
29,253 $608,000
Q1 2023

May 02, 2023

SELL
$21.42 - $32.08 $6,575 - $9,848
-307 Reduced 0.9%
33,934 $798,000
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $798,157 - $979,635
34,241 New
34,241 $956 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cognios Beta Neutral Large Cap Fund, LP Portfolio

Follow Cognios Beta Neutral Large Cap Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.